Although limited by small sample size, the presence of anti-dsDNA and low complement levels or an abnormality in either test in pregnant patients with previous nephritis and current remission, did not ...
Follow-up on phase 1 study of AT101, a novel anti-CD19 chimeric antigen receptor cell therapy (CAR-T) in patients with relapsed or refractory (r/r) b-cell non-Hodgkin lymphoma. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results